These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 26299768)
21. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma. Liu B; Hu Y; Qin L; Peng XB; Huang YX Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS. Long Y; Wu Z; Yang X; Chen L; Han Z; Zhang Y; Liu J; Liu W; Liu X Mol Med Rep; 2016 Sep; 14(3):2651-6. PubMed ID: 27485165 [TBL] [Abstract][Full Text] [Related]
23. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression. Fava G; Demorrow S; Gaudio E; Franchitto A; Onori P; Carpino G; Glaser S; Francis H; Coufal M; Marucci L; Alvaro D; Marzioni M; Horst T; Mancinelli R; Benedetti A; Alpini G Liver Int; 2009 Aug; 29(7):1031-42. PubMed ID: 19291182 [TBL] [Abstract][Full Text] [Related]
24. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro. Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253 [TBL] [Abstract][Full Text] [Related]
25. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183 [TBL] [Abstract][Full Text] [Related]
26. Abnormal expression of Forkhead Box J2 (FOXJ2) suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis. Qiang Y; Wang F; Yan S; Zhang H; Zhu L; Chen Z; Tu F; Wang D; Wang G; Wang W; Chen Z Int J Oncol; 2015; 46(6):2449-58. PubMed ID: 25873280 [TBL] [Abstract][Full Text] [Related]
27. The role of microRNAs in intrahepatic cholangiocarcinoma. Li Z; Shen J; Chan MT; Wu WK J Cell Mol Med; 2017 Jan; 21(1):177-184. PubMed ID: 27619971 [TBL] [Abstract][Full Text] [Related]
28. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome. Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598 [TBL] [Abstract][Full Text] [Related]
29. 14-3-3σ downregulation suppresses ICC metastasis via impairing migration, invasion, and anoikis resistance of ICC cells. Yang Z; Jin Q; Hu W; Dai L; Xue Z; Man D; Zhou L; Xie H; Wu J; Zheng S Cancer Biomark; 2017 Jul; 19(3):313-325. PubMed ID: 28482619 [TBL] [Abstract][Full Text] [Related]
30. miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1. Wan P; Chi X; Du Q; Luo J; Cui X; Dong K; Bing Y; Heres C; Geller DA J Cell Biochem; 2018 Dec; 119(12):9720-9729. PubMed ID: 30145803 [TBL] [Abstract][Full Text] [Related]
31. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection. Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma. Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158 [TBL] [Abstract][Full Text] [Related]
33. MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line. Iwaki J; Kikuchi K; Mizuguchi Y; Kawahigashi Y; Yoshida H; Uchida E; Takizawa T PLoS One; 2013; 8(7):e69496. PubMed ID: 23922722 [TBL] [Abstract][Full Text] [Related]
34. miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells. Qiu YH; Wei YP; Shen NJ; Wang ZC; Kan T; Yu WL; Yi B; Zhang YJ Cell Physiol Biochem; 2013; 32(5):1331-41. PubMed ID: 24280681 [TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of VEGF-C mRNA of extrahepatic cholangiocarcinoma with real-time PCR using samples obtained during endoscopic retrograde cholangiopancreatography. Dobashi A; Imazu H; Tatsumi N; Okabe M; Ang TL; Tajiri H Scand J Gastroenterol; 2013 Jul; 48(7):848-55. PubMed ID: 23721191 [TBL] [Abstract][Full Text] [Related]
36. Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites. Xie Y; Zhang H; Guo XJ; Feng YC; He RZ; Li X; Yu S; Zhao Y; Shen M; Zhu F; Wang X; Wang M; Balakrishnan A; Ott M; Peng F; Qin RY Cell Death Dis; 2018 Feb; 9(2):249. PubMed ID: 29445149 [TBL] [Abstract][Full Text] [Related]
37. Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells. Zhu H; Jiang X; Zhou X; Dong X; Xie K; Yang C; Jiang H; Sun X; Lu J Liver Int; 2018 Jan; 38(1):125-135. PubMed ID: 28618167 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of microRNA-204 inhibits cell proliferation, migration and invasion in human renal cell carcinoma cells by downregulating SOX4. Wu D; Pan H; Zhou Y; Zhang Z; Qu P; Zhou J; Wang W Mol Med Rep; 2015 Nov; 12(5):7059-64. PubMed ID: 26323722 [TBL] [Abstract][Full Text] [Related]
39. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach. Wang P; Lv L Oncotarget; 2016 Dec; 7(49):81367-81376. PubMed ID: 27833076 [TBL] [Abstract][Full Text] [Related]
40. Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer. Sakamoto K; Imai K; Higashi T; Taki K; Nakagawa S; Okabe H; Nitta H; Hayashi H; Chikamoto A; Ishiko T; Beppu T; Baba H Cancer Sci; 2015 Sep; 106(9):1153-62. PubMed ID: 26132727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]